Ohno Y, Spriggs D, Matsukage A, Ohno T, Kufe D
Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
Cancer Res. 1989 Apr 15;49(8):2077-81.
9-beta-D-Arabinofuranosyladenine (ara-A) is an inhibitor of DNA replication with antitumor and antiviral activity. The molecular basis for this inhibitory effect has remained unclear. The present work has examined the effects of 9-beta-D-arabinofuranosyladenine-triphosphate on DNA polymerase-beta. These studies were performed on different M13 phage DNA templates. The findings demonstrate that 9-beta-D-arabinofuranosyladenine is incorporated into the elongating DNA strand by DNA polymerase-beta. The findings also demonstrate that the incorporated 9-beta-D-arabinofuranosyladenine residue acts as a relative chain terminator. Furthermore, the relative chain-terminating effects of this agent are sequence specific and reversed by competition with deoxyadenosine-triphosphate for incorporation into the DNA strand. These findings are in concert with hydrogen bonding differences of the incorporated arabinosyl moiety which alters reactivity of the chain terminus and thereby inhibits elongation. These findings are also in agreement with recent studies of 1-beta-D-arabinofuranosylcytosine and provide insights into the sequence specific effects of these agents.
9-β-D-阿拉伯呋喃糖基腺嘌呤(ara-A)是一种具有抗肿瘤和抗病毒活性的DNA复制抑制剂。这种抑制作用的分子基础尚不清楚。目前的工作研究了9-β-D-阿拉伯呋喃糖基腺嘌呤三磷酸对DNA聚合酶β的影响。这些研究是在不同的M13噬菌体DNA模板上进行的。研究结果表明,9-β-D-阿拉伯呋喃糖基腺嘌呤被DNA聚合酶β掺入正在延长的DNA链中。研究结果还表明,掺入的9-β-D-阿拉伯呋喃糖基腺嘌呤残基起到了相对链终止剂的作用。此外,该试剂的相对链终止作用具有序列特异性,并且通过与脱氧腺苷三磷酸竞争掺入DNA链而被逆转。这些发现与掺入的阿拉伯糖基部分的氢键差异相一致,这种差异改变了链末端的反应性,从而抑制了延伸。这些发现也与最近对1-β-D-阿拉伯呋喃糖基胞嘧啶的研究一致,并为这些试剂的序列特异性作用提供了见解。